Top Markets
Coin of the day
Duality Biotherapeutics, Inc. Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc.

9606
Rank in Stocks #6046
Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc.... Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc. concentrates on pioneering next-generation antibody-drug conjugate (ADC) therapies and proprietary duality immune toxin antibody conjugate (ITAC) solutions. The firm was founded by Zhu Zhong Yuan on July 3, 2019, and its main offices are situated in Shanghai, China.
Share Price
$25.01
Market Cap
$2.26B
Change (1 day)
-1.21%
Change (1 year)
-37.74%
Country
CN
Trade Duality Biotherapeutics, Inc. (9606)

Category

EPS for Duality Biotherapeutics, Inc. (9606)
EPS as of 2026 TTM: 0
According to Duality Biotherapeutics, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Duality Biotherapeutics, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
$-5.29 -
AU
$-7.98 -
US
- -
CH